Chemical Structure
Topiramate
Product Images NDC 63629-4947
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 63629-4947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1
The text describes a figure labeled "Figure 1" which presents the Kaplan-Meier estimates of cumulative rates for time to first seizure. The figure compares the rates for two groups: one taking Topiramate 50 mg/day (N=234), and one taking Topiramate 400 mg/day (N=236). The x-axis shows time (in days) and the y-axis shows the percentage of participants who have not experienced a seizure. The figure suggests that the group taking Topiramate 400 mg/day experiences a slower rate of seizures compared to the group taking Topiramate 50 mg/day.*
Lbl636294947
The package contains Topiramate 200mg tablets manufactured by Sun Pharma Industries Ltd. It's a prescription medicine used to treat epilepsy and migraine headaches, and should be stored at room temperature. The package includes 30 tablets with NDC 6362949471 and has an expiration date of MM/YY. The package was prepackaged by Bryant Ranck Prepack Bunbauk.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
